Alexis Borisy
Chairman, Nextech Invest; Chairman, Curie.Bio
Alexis Borisy is a leading biotechnology entrepreneur and investor with 30 years of experience building, operating and investing in innovative science-based companies to make a positive difference in the world. Alexis is the co-founder and operating Chairman of Curie.Bio, a new founder-focused model for venture in biotech. Through his Borisy Labs Productions, LLC, Alexis continues to found and participate in the initial build of innovative biotech companies, such as IDRx, Inc. and Sesame Therapeutics. Alexis serves on multiple boards, both public and private, of companies that he helped to found or build, and he also serves as Chairman of Nextech Invest, a Swiss-American venture firm. He is currently chairman of the Board of Trustees of the Boston Museum of Science, has served on the board of BIO and was formerly the chairman of the National Venture Capital Association.
Alexis has founded or served as CEO or Chairman of over 15 biotechs, including 10 that have gone public on the NASDAQ and multiple that have been acquired. Of particular note, Alexis co-founded Foundation Medicine (FMI), served as its first CEO, and then chairman, remaining on the board until the $5B acquisition by Roche. He also co-founded Blueprint Medicines (BPMC), served as interim CEO and continues to serve on the board. Alexis co-founded, served as CEO and currently is chairman of Relay Therapeutics (RLAY), and was a founding investor and is chairman of Tango Therapeutics (TNGX). He co-founded EQRx and was a founding investor in Revolution Medicines (RVMD) where he continues to serve as Lead Independent Director.
Graduate trained in chemistry and chemical biology at Harvard where he was a Howard Hughes predoctoral fellow, Alexis was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences, was honored as a Presidential Scholar, and holds an undergraduate degree in chemistry from the University of Chicago.